THE ONLY NON-INVASIVE SOLUTION THAT OPENS A CLEAR WINDOW INTO PATIENTS’ HEMODYNAMIC AND FLUID STATUS

YOUR WINDOW TO THE HEART

NICaS is an easy to use, non-invasive, actionable, robust & cost- effective system for the challenging task of treatment and monitoring of hemodynamic and fluid management problems

OUR VISION

We strive to provide non-invasive solutions to the various challenges in the cardiovascular field. These range from Hypertension, CHF, Hemodialysis, ICU/CCU, Neonatal, to the the treatment of infectious diseases.
Our goal is to provide a much needed solution for non-invasive hemodynamic and fluid management in both inpatient and outpatient settings

OUR SOLUTIONS

Stroke Volume and Cardiac Output are basic vital signs that enable physicians to better treat and monitor their patients in a wide array of clinical applications.

As the traditional methods to measure these parameters require invasive procedures, such as Thermodilution or Fick that require insertion of a catheter, parameter use is limited.

Our non-invasive technology enables physicians, whenever they are, to measure these parameters in a variety of settings including hospitals, clinics, and patients’ homes.

This leads to improved medical outcomes, both chronically and acutely, in a wide variety of clinical applications, including: Heart Failure management, Hypertension control, Hemodialysis, Preeclampsia, CRT optimization, Hemodynamic management during anesthesia, and more.

CLINICAL APPLICATION

THE CHALLENGE

OUR SOLUTION

HEART FAILURE

Average Readmission Rate for patients with HF is 30%

Using NICaS for management of HF patients reduces Hospital
Readmission Rate by over 90%

HYPERTENSION

Only 50% of Hypertensive patients in the US are
under control

Customers who are using NICaS for management of hypertension have reported control rate of over 90%

Preeclampsia

Preeclampsia and eclampsia can lead to  increased risks of significant maternal and perinatal adverse outcomes, including death.

NICaS is designed to assist physicians in finding the exact cause of hypertension, thus significantly reducing these risks.

DIALYSIS

Although crucial for proper patient treatment, the dry weight and hemodynamic profile of patients are estimated rather than measured. This results in sub-optimal treatment and a high percentage of hospitalizations

NICaS can provide each
patient hemodynamic
profile allowing to set
more accurate dry weight
and treatment strategy
and thus reduce the
amount of unnecessary
hospitalizations

ICU/ICCU

While hemodynamic information is crucial for patient management in the ICU, this data is only available for 20-30% of patients.
NICaS Navigator™ provides safe, accurate and continuous information regarding patients’ cardiorespiratory profile.

COVID 19

Due to the pandemic, many healthcare systems are overwhelmed and unable to provide optimal respiratory treatment to their patients. In addition, over 20% of COVID 19 patients develop cardiac injury, on top of patients with preexisting cardiac conditions

NICaS can provide accurate and continuous cardiorespiratory
information to optimize the treatment
for patients with ARDS. While limiting
the exposure of medical teams,
it also helps reduce risk of infection.

Pharma Clinical trials

Many drug developers are struggling to evaluate the compounds for cardiac efficacy and safety. This is due to the high cost and reproducibility limitation of current methods such as Echocardiography and Thermodilution

NICaS provides a cost-effective and easy
to use system. With its highly accurate,
sensitive and reproducible information,
NiCaS helps speed up the drug development process.

NICaS MODULAR AND COMPACT DESIGN MAKES IT ACCESSIBLE AND EASY TO USE IN VARIOUS MEDICAL SETTINGS:

CARDIAC ICUs, GENERAL ICUs, INTERNAL WARDS, ERs, ORs, CHF AND HYPERTENSION CLINICS, DIALYSIS, NURSING HOMES, PRIVATE CLINICS, PATIENTS’ HOME

EASY SETUP

Connect to any device (tablets, laptops, desktops) Easy and quick installation process.

SIMPLE OPERATION

No need to shave or undress the patients . Only two sensors are required.

REPORT

Flexible and easy to read.
Helps treating physicians prioritize
hemodynamic and fluid parameters

SOME OF OUR REGULATORY
APPROVALS / CLEARANCES

LOCATIONS & DISTRIBUTORS

NI Medical is represented in many countries in North America, South America, Europe and Asia Pacific. In case we do not have a distributor or partner in the country you are looking for, please contact us directly at our headquarter.

THE ONLY NON-INVASIVE SOLUTION THAT OPENS A CLEAR WINDOW INTO PATIENTS’ HEMODYNAMIC AND FLUID STATUS

YOUR WINDOW TO THE HEART

NICaS is an easy to use, non-invasive, actionable, robust & cost- effective system for the challenging task of treatment and monitoring of hemodynamic and fluid management problems

Watch NICaS Intro:

Play Video

OUR VISION

We strive to provide non-invasive solutions to the various challenges in the cardiovascular field. These range from Hypertension, CHF, Haemodialysis, ICU/CCU, Neonatal, to the the treatment of infectious diseases. Our goal is to provide a much needed solution for non-invasive hemodynamic and fluid management in both inpatient and outpatient settings

OUR SOLUTIONS

Stroke Volume and Cardiac Output are basic vital signs that enables the treating  physician  to better treat and monitor their patients in a wide array of clinical applications.

As the traditional methods to measure these parameters require invasive procedure such as the insertion of a catheter and therefore the use of    of these parameters are limited.

Our Non Invasive technology, enable physicians, whenever they are, to measure these parameters in a variety of settings hospital, clinic, patient home) 

This will lead to improved medical outcomes, both chronically and acutely,  in a wide clinical applications including: Heart Failure management, Hypertension control, Hemodialysis, Preeclampsia, CRT optimization, Hemodynamic management during anesthesia and more.

HEART FAILURE

THE CHALLENGE:

Average readmission rate for
Patient with HF is 30%

OUR SOLUTION:

Using NICaS for management of HF patients reduces Hospital
Readmission rate by over 90%

Read More >

HYPERTENSION

THE CHALLENGE:

Only 50% of Hypertensive patients
in the US are under control

OUR SOLUTION:

Customers who are using NICaS for management of hypertension have reported control rate of over 90%
Read More >

Preeclampsia

THE CHALLENGE:

Preeclampsia and eclampsia can lead to increased risks of significant maternal and perinatal adverse outcomes, including death.

OUR SOLUTION:

NICaS is designed to assist physicians in finding the exact cause of hypertension, thus significantly reducing these risks.

Read More >

DIALYSIS

THE CHALLENGE:

Although crucial for proper patient treatment, the dry weight and hemodynamic profile of patients are estimated rather than measured. This results in sub-optimal treatment and a high percentage of hospitalizations

OUR SOLUTION:

NICaS can provide each patient hemodynamic profile allowing to set more accurate dry weight and treatment strategy and thus reduce the amount of unnecessary hospitalizations
Read More >

ICU/ICCU

THE CHALLENGE:

While Hemodynamic Information is crucial for Patient management in the ICU only this data is only available for 20-30%

OUR SOLUTION:

NICaS Navigator™ provides safe, accurate and continuous information regarding patients’ cardiorespiratory profile.
Read More >

COVID 19

THE CHALLENGE:

Due to the pandemic many healthcare systems are being overwhelmed and are unable to provide optimal respiratory treatment to their patients, in addition over 20% of COVID 19 patients develop cardiac injury (this is in addition to the patient with pre-existing cardiac conditions)

OUR SOLUTION:

NICaS can provide an accurate continuous cardiorespiratory information to optimise the treatment for patient with ARDS, while limiting the exposure of medical team and thus risk of infection

Read More >

Pharma Clinical trials

THE CHALLENGE:

Many drug developers are struggling to evaluate the compounds for cardiac efficacy and safety, due to the high cost and reproducibility limitation of the current methods such as Echocardiography and Thermodilution

OUR SOLUTION:

NICaS provides cost effective easy to use highly accurate, sensitive and reproducible hemodynamic information allowing to speed up the drug development process

Read More >

NICaS MODULAR AND COMPACT DESIGN MAKES IT ACCESSIBLE AND EASY TO USE IN VARIOUS MEDICAL SETTINGS:

CARDIAC ICUs, GENERAL ICUs, INTERNAL WARDS, ERs, ORs, CHF AND HUYPERTENSION CLINICS, DIALYSIS, NURSING HOMES, PRIVATE CLINICS, PATIENTS’ HOME PATIENTS’ HOME

EASY SETUP

Connect to any device (tablets, laptops, desktops) Easy and quick installation process.

SIMPLE OPERATION

No need to shave or undress the patients . Only two sensors are required.

REPORT

Flexible and easy to read. Helps treating physicians prioritize hemodynamic and fluid parameters

SOME OF OUR Regulatory Approvals / Clearances:

LOCATIONS & DISTRIBUTORS

NI Medical is represented in many countries in North America, South America, Europe and Asia Pacific. In case we do not have a distributor or partner in the country you are looking for, please contact us directly at our headquarter.